Can-Fite BioPharma Ltd. (CANF) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $405.0K | -39.9% |
| 2024 | $674.0K | -9.3% |
| 2023 | $743.0K | -8.3% |
| 2022 | $810.0K | -5.0% |
| 2021 | $853.0K | +11.8% |
| 2020 | $763.0K | -62.5% |
| 2019 | $2.03M | -46.8% |
| 2018 | $3.82M | +384.2% |
| 2017 | $789.0K | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $405.0K | -39.9% |
| 2024 | $674.0K | -9.3% |
| 2023 | $743.0K | -8.3% |
| 2022 | $810.0K | -5.0% |
| 2021 | $853.0K | +11.8% |
| 2020 | $763.0K | -62.5% |
| 2019 | $2.03M | -46.8% |
| 2018 | $3.82M | +384.2% |
| 2017 | $789.0K | — |